Xi Y. Li
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Verteporfin-loaded hydrogel targeting YAP-mediated MDSCs recruitment for the treatment of residual tumors after incomplete radiofrequency ablation.
Journal: Theranostics
Published: June 11, 2025
Correction:Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
Journal: Journal of nanobiotechnology
Published: August 02, 2024
Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
Journal: Journal of nanobiotechnology
Published: January 16, 2024
STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 03, 2023
Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1.
Journal: Journal of translational medicine
Published: January 02, 2023
Social identity loss and reverse culture shock: Experiences of international students in China during the COVID-19 pandemic.
Journal: Frontiers in psychology
Published: July 14, 2022
Two Foxo1 homologues in the orange-spotted grouper Epinephelus coioides: sequences, expression, and possible involvement in the activation of cyp19a1a expression in the ovary.
Journal: Fish physiology and biochemistry
Published: February 15, 2021
Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice.
Journal: Acta pharmaceutica Sinica. B
Published: January 14, 2017
Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.
Journal: Journal of translational medicine
Published: April 19, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026